Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (111-120 of 638) with videos related to

Pageof 64
Sort By:
Circulation Research|May 15, 2004
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cellsNikolaus Marx, Hélène Duez, Jean-Charles Fruchart, et al.
Journal De La Societe De Biologie|July 24, 2002
[Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control]Virginie Bocher, Giulia Chinetti, Jean-Charles Fruchart, et al.
Journal of Cellular and Molecular Medicine|November 5, 2011
Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?Morgane Baron, Chantal M Boulanger, Bart Staels, et al.
The Proceedings of the Nutrition Society|November 17, 2016
Intestinal bile acid receptors are key regulators of glucose homeostasisMohamed-Sami Trabelsi, Sophie Lestavel, Bart Staels, et al.
Trends in Endocrinology and Metabolism: TEM|September 8, 2004
Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymesOlivier Barbier, Coralie Fontaine, Jean-Charles Fruchart, et al.
The Journal of Clinical Investigation|March 3, 2006
Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasisPhilippe Lefebvre, Giulia Chinetti, Jean-Charles Fruchart, et al.
Endocrinology|March 8, 2008
Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase responseRoxane M Mansouri, Eric Baugé, Bart Staels, et al.
Expert Opinion on Emerging Drugs|August 31, 2006
Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosisBenoit Pourcet, Jean-Charles Fruchart, Bart Staels, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|February 10, 2016
Metabolic effects of bile acid sequestration: impact on cardiovascular risk factorsValeria Spinelli, Oscar Chávez-Talavera, Anne Tailleux, et al.
Endocrinology|February 17, 2005
Farnesoid X receptor: a new player in glucose metabolism?Bertrand Cariou, Daniel Duran-Sandoval, Folkert Kuipers, et al.
Pageof 64

Showing results (111-120 of 638) with videos related to

Sort By:
Pageof 64
Circulation Research|May 15, 2004
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cellsNikolaus Marx, Hélène Duez, Jean-Charles Fruchart, et al.
Journal De La Societe De Biologie|July 24, 2002
[Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control]Virginie Bocher, Giulia Chinetti, Jean-Charles Fruchart, et al.
Journal of Cellular and Molecular Medicine|November 5, 2011
Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?Morgane Baron, Chantal M Boulanger, Bart Staels, et al.
The Proceedings of the Nutrition Society|November 17, 2016
Intestinal bile acid receptors are key regulators of glucose homeostasisMohamed-Sami Trabelsi, Sophie Lestavel, Bart Staels, et al.
Trends in Endocrinology and Metabolism: TEM|September 8, 2004
Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymesOlivier Barbier, Coralie Fontaine, Jean-Charles Fruchart, et al.
The Journal of Clinical Investigation|March 3, 2006
Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasisPhilippe Lefebvre, Giulia Chinetti, Jean-Charles Fruchart, et al.
Endocrinology|March 8, 2008
Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase responseRoxane M Mansouri, Eric Baugé, Bart Staels, et al.
Expert Opinion on Emerging Drugs|August 31, 2006
Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosisBenoit Pourcet, Jean-Charles Fruchart, Bart Staels, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|February 10, 2016
Metabolic effects of bile acid sequestration: impact on cardiovascular risk factorsValeria Spinelli, Oscar Chávez-Talavera, Anne Tailleux, et al.
Endocrinology|February 17, 2005
Farnesoid X receptor: a new player in glucose metabolism?Bertrand Cariou, Daniel Duran-Sandoval, Folkert Kuipers, et al.
Pageof 64